StonvexLoading…
StonvexStonvexStonvexCore line items from BPRN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $130.55M | $122.95M | $98.18M | $74.08M |
Operating Income | $23.68M | $12.82M | $30.34M | $34.05M |
Net Income | $18.61M | $10.24M | $25.77M | $26.49M |
EPS (Diluted) | $2.71 | $1.55 | $4.03 | $4.11 |
Total Assets | $2.29B | $2.34B | $1.92B | $1.60B |
Total Liabilities | $2.01B | $2.08B | $1.68B | $1.38B |
Cash & Equivalents | $135.69M | $117.35M | $150.56M | $53.35M |
Free Cash Flow OCF − CapEx | $20.60M | $13.21M | $21.40M | $23.38M |
Shares Outstanding | 6.77M | 6.88M | 6.30M | 6.25M |